Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment

H. H. Garcia, R. H. Gilman, J. Horton, M. Martinez, G. Herrera, J. Altamirano, J. M. Cuba, N. Rios-Saavedra, M. Verastegui, J. Boero, A. E. Gonzalez

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Albendazole therapy for neurocysticercosis: A prospective double-blind trial comparing 7 versus 14 days of treatment'. Together they form a unique fingerprint.

Medicine & Life Sciences